Experimental drugs poised for use in Ebola outbreak

International health organizations are in discussions with the Democratic Republic of Congo about how and whether to deploy treatments in addition to a vaccine.

Like Comment

Aid workers responding to the Ebola virus outbreak in the Democratic Republic of Congo (DRC) are seeking approval to treat patients with experimental drugs. These include three potential treatments — ZMapp, favipiravir and GS-5734 — that were given to patients during the 2014–16 Ebola outbreak in West Africa. The three drugs are being considered in addition to an existing plan to deploy an experimental vaccine; none of the treatments has been definitively proved to lower the risk of death from Ebola.

By Erika Check Hayden, Nature News

Source: https://www.nature.com/articles/d41586-018-05205-x 

No comments yet.